login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
INVENTIVA SA - ADR (IVA) Stock News
USA
- NASDAQ:IVA -
US46124U1079
-
ADR
5.53
USD
+0.17 (+3.17%)
Last: 10/9/2025, 9:20:23 PM
5.05
USD
-0.48 (-8.68%)
After Hours:
10/9/2025, 9:20:23 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IVA Latest News, Press Relases and Analysis
All
Press Releases
17 hours ago - By: Benzinga
- Mentions:
HELE
PLUG
AZZ
RACE
...
Helen of Troy, Ferrari, Apogee Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
4 days ago - By: Benzinga
- Mentions:
IP
IVR
NAT
MESO
...
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session
a month ago - By: Zacks Investment Research
How Much Upside is Left in Inventiva (IVA)? Wall Street Analysts Think 100.79%
a year ago - By: Yahoo Finance
Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday?
2 years ago - By: The Motley Fool
- Mentions:
MDGL
GALT
GLMD
VKTX
...
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Please enable JavaScript to continue using this application.